Edition:
India

People: Concert Pharmaceuticals Inc (CNCE.OQ)

CNCE.OQ on NASDAQ Stock Exchange Global Market

11.41USD
1:30am IST
Change (% chg)

$-0.12 (-1.04%)
Prev Close
$11.53
Open
$11.48
Day's High
$11.57
Day's Low
$11.25
Volume
30,191
Avg. Vol
45,485
52-wk High
$13.09
52-wk Low
$5.48

Tung, Roger 

Dr. Roger D. Tung Ph.D. serves as President, Chief Executive Officer, Co-Founder, Director of the Company. He is our scientific founder and has served as our President and Chief Executive Officer and as a member of our Board since April 2006. Before founding Concert, Dr. Tung was a founding scientist at Vertex Pharmaceuticals Incorporated, a pharmaceutical company, where he was employed from 1989 to 2005, most recently as its Vice President of Drug Discovery. Prior to Vertex, he held various positions at Merck, Sharp & Dohme Research Laboratories, a global healthcare provider, and The Squibb Institute for Medicinal Chemistry. During the last five years, Dr. Tung previously served on the board of directors of Flex Pharma, Inc. Dr. Tung received a B.A. in Chemistry from Reed College and a Ph.D. in Medicinal Chemistry from the University of Wisconsin-Madison. We believe that Dr. Tung’s detailed knowledge of Concert and his long career in the global pharmaceutical and biotechnology industries, including his roles at Vertex, make him a key contributor to our Board.

Basic Compensation

Total Annual Compensation, USD 562,287
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 2,210,060
Fiscal Year Total, USD 2,772,350

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Aldrich

157,592

Roger Tung

2,772,350

Marc Becker

1,887,420

Nancy Stuart

1,908,030

James Cassella

1,695,040

Jeffrey Munsie

--
As Of  31 Dec 2019